Clinical Trial Update: A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) [Phase 3]

View source ↗

Summary

A Phase 3 trial update for V503 HPV vaccine in preadolescents/adolescents is completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Genital Lesions
• Hpv Infections
• Pap Test Abnormalities
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• V503

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cervical Cancers, Vulvar Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-01-13